Pregnancy during the pandemic:
The impact of COVID-19-related stress on risk for prenatal depression
Lucy S. King1, Daisy E. Feddoes1, Jacklyn S. Kirshenbaum1,
Kathryn L. Humphreys2, & Ian H. Gotlib1
1Department of Psychology, Stanford University
2Deparment of Psychology and Human Development, Vanderbilt University
Conflict of Interest
The authors have no conflicts of interest to report.
Data and Code Availability
Acknowledgements
Funding was provided by the National Institutes of Health (IHG, R21 MH111978; R21
HD090493); the National Science Foundation (JSK, Graduate Student Research Fellowship);
and the Jacobs Foundation (KLH, Early Career Research Fellowship 2017-1261-05). We thank
Drs. Moriah Thomason and Michelle VanTiegham at New York University and Drs. Alice
Graham and Elinor Sullivan at Oregon Health and Science University for leading the
development of the survey materials used in this project. We also thank the participants for their
contributions.
Corresponding author:
Lucy S. King
Department of Psychology, Stanford University
Jordan Hall, 450 Serra Mall, Building 420
Stanford, CA 94305, USA
lucyking@stanford.edu
Abstract
Pregnant women may be particularly sensitive to negative events (i.e., adversity) related
to the COVID-19 pandemic and affective responses to these events (i.e., stress). We examined
COVID-19-related stress and adversity in a sample of 725 pregnant women residing in the San
Francisco Bay Area in March-May 2020, 343 of whom provided addresses in California that
were geocoded and matched by census tract to measures of community-level risk factors.
Women who were pregnant during the pandemic had substantially elevated depressive
symptoms compared to matched women who were pregnant prior to the pandemic. Several
individual- and community-level risk and protective factors were associated with women‚Äôs
scores on two latent factors of COVID-19-related stress and adversity. Highlighting the role of
subjective responses to the pandemic in vulnerability to prenatal depression and factors that
influence susceptibility to COVID-19-related stress, these findings inform understanding of the
psychosocial sequelae of disease outbreaks among pregnant women.
Introduction
Women experience dramatic metabolic, hormonal, and physical changes during
pregnancy and childbirth that occur in synchrony with the rapid development of the fetus
(C√°rdenas, Kujawa, & Humphreys, 2020). Because the prenatal period is marked by striking
neurobiological plasticity, it is a time of enhanced sensitivity to the environment for both mothers
and their fetuses (Bock, Wainstock, Braun, & Segal, 2015). The novel coronavirus disease 2019
(COVID-19) pandemic is a public health disaster involving widespread increases in exposure to
environmental adversity, defined as negative life events related to the environment (e.g.,
financial losses), as well as psychosocial stress, defined as affective responses to these events
(e.g., changes in subjective distress and underlying physiology; Barrero-Castillero, Morton,
Nelson, & Smith, 2019). There is documented inequality in the impact of the COVID-19
pandemic, such that those with historically marginalized identities (e.g., women, people of color,
lower income people) are experiencing more numerous and severe social, economic, and
psychological challenges due to the pandemic (Fancourt, Steptoe, & Bu, 2020; O‚ÄôConnor et al.,
2020). Pregnant women are a special population for whom stress and adversity related to the
pandemic may have specific characteristics. In particular, pandemic-related stress and adversity
may lead to or exacerbate common prenatal mental health difficulties, including depressive
symptoms, which, in turn, have been found to negatively influence maternal‚Äìchild health
(Glover, 2014).
Disasters and disease outbreaks are complex humanitarian events that give rise to
many forms of individual-level adversity (Beaglehole et al., 2018; Chew, Wei, Vasoo, & Sim,
2020). Similar to other disasters and epidemics, the COVID-19 pandemic has the potential to
increase stress and adversity; however, this pandemic is unprecedented in its characteristics
and the reach of its impact (O‚ÄôConnor et al., 2020). It involves distinct adverse experiences,
such as prolonged social isolation due to social distancing requirements, and specific stress
responses, such as ongoing fears of contracting a highly virulent virus that, as of late December
2020, has taken the lives of 1.75 million people. Further, COVID-19 has led to a severe
economic recession that disproportionally affects women (Heggeness, 2020; U.S. Bureau of
Labor Statistics, 2020). During this time, pregnant women may experience fear for the health of
their future infant, worries about their own wellbeing during what is often the most medically
vulnerable period of their life, and disruptions to their obstetric care (Preis, Mahaffey,
Heiselman, & Lobel, 2020). These fears are not ungrounded. Pregnant women who contract
COVID-19 are more likely to experience severe illness, to die from the virus, to have preterm
births, and to experience childbirth-related posttraumatic stress disorder symptoms
(Mayopoulos et al., 2020; Woodworth et al., 2020; Zambrano et al., 2020). By taxing the
healthcare system, COVID-19 may also indirectly affect pregnant women‚Äôs health by negatively
influencing the prenatal medical care they receive (Roberton et al., 2020). Due to the dual
impact of prenatal stress and adversity on women and their fetuses (Van den Bergh et al.,
2017), characterizing COVID-19-related stress and adversity in pregnant women is a public
health priority. Specifically, by characterizing the nature of pregnant women‚Äôs experiences of
stress and adversity during this pandemic and the impact of these experiences on their
psychological health, we can inform policies that help to alleviate women‚Äôs suffering and prevent
its negative consequences on the next generation of children during COVID-19 and future
disease outbreaks.
Stress and adversity in any form can be depressogenic (Hammen, 2005), including
during or after disasters (Gruebner et al., 2016; Norris, Tracy, & Galea, 2009; Self-Brown, Lai,
Harbin, & Kelley, 2014). Although research examining the psychological effects of disease
outbreaks prior to COVID-19 is limited, studies have documented elevated depressive
symptoms in general population samples following the severe acute respiratory syndrome
(SARS) and Ebola epidemics (Chew et al., 2020). With respect to COVID-19, emerging findings
indicate that depressive symptoms were elevated in the general population compared to
historical norms in the weeks following the first shelter-in-place orders in the U.S. and the U.K.
(Fancourt et al., 2020; Nelson, Pettitt, Flannery, & Allen, 2020). In a U.S. nationally
representative sample, Ettman et al. (2020) found the presence of depressive symptoms during
COVID-19 to be 27.8%, compared to 8.5% in a representative sample assessed prior to the
pandemic. Initial studies indicate that 24-33% of postpartum women have reported clinically
significant depression during the pandemic (Cameron et al., 2020; Thayer & Gildner, 2020; as
indicated by scores on the Edinburgh Postnatal Depression Scale [EPDS; Cox, Holden, &
Sagovsky, 1987] ‚â• 13 and ‚â• 15, respectively). From a cumulative risk perspective, pregnant
women may be especially vulnerable to experiencing depressive symptoms during COVID-19
because pregnancy itself can be stressful, involving mental and physical preparation for
dramatic life changes that can be challenging even when they are welcome (Saxbe,
Goldenberg, & Rossin-Slater, 2018). Thus, for pregnant women, it is possible that COVID-19 is
an additional psychosocial burden superimposed on an already challenged system. In this
context, pregnant women, as a group, may be more likely to experience elevated depressive
symptoms in response to the pandemic than are non-pregnant people, and among pregnant
women, those who experience more severe pandemic-related stress and adversity may be at
highest risk.
Based on a bioecological model of human development, both proximal processes that
vary at the level of the individual and distal factors that vary across community systems
influence the nature of individuals‚Äô exposure and responses to mass adversity (Bronfenbrenner,
1994; Hoffman & Kruczek, 2011). For example, whereas some individuals may already have
resources in place (e.g., social support) that protect them from stress and adversity related to
the COVID-19 pandemic, others may lack these resources and/or have characteristics that
predispose them to greater stress and adversity during this time (e.g., physical health
conditions; McElroy et al., 2020). Characteristics of one‚Äôs community, such as the population‚Äôs
health and socioeconomic standing relative to other places, may also affect levels of stress and
adversity by influencing social distancing, disease transmission, and mortality (Adhikari et al.,
2020; Jay et al., 2020). Identifying risk and protective factors for stress and adversity related to
the COVID-19 pandemic in pregnant women will advance our understanding of who in that
population is most vulnerable to the psychosocial sequelae of this pandemic. As the immediate
and longer-term consequences of the pandemic continue to unfold, these data will be useful for
guiding prenatal care practices based on patient-level variables and for the allocation of public
health resources for pregnant women based on the characteristics of communities.
We had four goals in the current study, in which we examined stress and adversity
related to the COVID-19 pandemic in a large sample of pregnant women residing predominantly
in the San Francisco Bay Area in March-May 2020. In Aim 1, we tested the hypothesis that,
compared to women who were pregnant prior to the onset of the COVID-19 pandemic, women
who were pregnant during the pandemic have higher self-reported symptoms of depression,
indicating that the pandemic has depressogenic effects on pregnant women. In Aim 2, to
characterize stress and adversity in pregnant women during the pandemic, we explored the
latent structure of pregnant women‚Äôs reports of stress and adversity related to COVID-19 using
dimensionality reduction techniques. In Aim 3, we used a machine-learning approach to identify
risk and protective factors that are associated with dimensions of COVID-19 stress and
adversity, including both individual-level characteristics (e.g., self-reported social support) and
community-level factors (e.g., community health at the census-tract level). Finally, in Aim 4, we
examined the associations between dimensions of COVID-19 stress and adversity and women‚Äôs
depressive symptoms, and, using machine-learning, identified the single indicators of stress and
adversity that are most strongly associated with prenatal depressive symptoms. Given that the
global incidence of infectious disease outbreaks is rising (Smith et al., 2014), the current study
elucidates the psychosocial impact on pregnant women of the COVID-19 pandemic specifically,
but also informs our understanding of the possible effects of future outbreaks on pregnant
women.
Method
Participants
Participants included independent samples of pregnant women residing predominantly in
the San Francisco Bay Area who participated in the Brain and Behavior Infants Experiences
project (BABIES; Humphreys, King, Choi, & Gotlib, 2018; King, Querdasi, Humphreys, & Gotlib,
2020) prior to the COVID-19 pandemic (hereafter, the ‚Äúpre-pandemic‚Äù cohort), or who
participated in the Stanford COVID-19 Perinatal Experiences (COPE) project following the onset
of the COVID-19 pandemic in the United States and state-wide shelter-in-place orders in
broader COPE project). These projects were separate in their original design and aims.
Pre-pandemic Cohort. Ninety women participated during their pregnancies in a
longitudinal study of the association between perinatal experiences and infant and toddler
psychobiological development from February 2017-May 2019. Of these women, two did not
complete an assessment of their prenatal depressive symptoms and, therefore, were not
included in the current analyses. Thus, the final pre-pandemic sample for the current analyses
included 88 women. All women resided in the San Francisco Bay Area at the time of study
participation.
COVID-19 Cohort. Pregnant women completed an online survey about COVID-19
stress and adversity and current mental health difficulties in April 2020. Of the 1,994 women
who responded to the online survey for the Stanford COPE Project, 1,595 were eligible for the
broader study based on being currently pregnant or the mother of an infant < 6 months old. Of
eligible women, 1,058 were currently pregnant. 333 of these pregnant women did not complete
the entire survey, yielding a final sample for the current analyses of 725 pregnant women. Of
the 428 women who provided any information about their current address, 353 resided in
California. Of these 353 women, 343 provided their complete current addresses, of whom 333
resided in counties in the Bay Area.
Procedure
Both the BABIES and COPE projects were approved by the Stanford Institutional
Review Board. Participants in both cohorts were recruited during their pregnancies through
online advertisements. Advertisements were active for the pre-pandemic cohort in February
2017-May 2019 and during a single week in early April 2020 for the COVID-19 cohort. Data for
both cohorts were collected and managed using REDCap electronic data capture tools hosted
at Stanford University (Harris et al., 2019, 2009).
Pre-pandemic Cohort. Participants were screened for inclusion/exclusion criteria
through a phone interview. Inclusion criteria were that they were currently pregnant, were ÔÇ≥ age
18 years, were fluent in English, and had no immediate plans to leave the geographic area.
Exclusion criteria included bipolar disorder, psychosis, or severe learning disabilities that would
impair the ability to participate in the study procedures. Further, due to the goals of the broader
BABIES project, participants were recruited to be enriched for a history of major depressive
disorder (MDD), current MDD, and/or early life adversity. Risk for MDD and early life adversity
was evaluated during the phone screening interview using questions from the Center for
Epidemiologic Studies Depression scale (Lewinsohn, Seeley, Roberts, & Allen, 1997) and the
Childhood Trauma Questionnaire (Bernstein et al., 1994). Participants who met
inclusion/exclusion criteria and agreed to participate attended an in-person session (1-2 hours)
in the Department of Psychology at Stanford University where they provided informed written
consent and completed a series of questionnaires, interviews, and computer tasks. Participants
were compensated for their time.
COVID-19 Cohort. Participants were screened for inclusion/exclusion criteria using
questions containing branching logic at the beginning of the online survey. Inclusion criteria for
the broader study were that participants were either currently pregnant or had an infant < 6
months old and were ÔÇ≥ age 18 years. In contrast to the pre-pandemic cohort, participants were
unselected for risk for depression or early life adversity. The survey and advertisements were in
English and also translated into Spanish. Participants who met criteria and agreed to participate
provided informed written consent and responded to a series of questions about their
experiences related to the pandemic as well as questionnaires measuring symptoms of
psychopathology (~20 minutes). Participants were entered into a random raffle for one of 25
online gift cards.
Measures
Demographic Characteristics. Participants in both cohorts self-reported their race and
ethnicity, level of education, marital status, their country of birth (from which we identified
whether they were a U.S. immigrant), their type of housing, their employment status, their
annual household income in the previous year, and the number of adults and children in their
household. We calculated their income-to-federal poverty line (FPL) ratio based on the number
of adults and children in their household. Notably, cost of living in California, especially in the
Bay Area, is extremely high; although California is among the wealthier states when considering
raw income relative to the FPL, it has the highest rate of poverty in the country when accounting
for cost of living (Fox, 2020). Thus, we anticipated that most participants would have household
incomes above the FPL. Participants also reported whether or not this was their first pregnancy
and their due dates. We calculated gestational weeks based on due date.
Prenatal Depressive Symptoms. Participants in both the pre-pandemic and COVID-19
cohorts completed the EPDS (Cox, Holden, & Sagovsky, 1987). The EPDS is a self-report
questionnaire consisting of 10 items assessing symptoms of depression (e.g., ‚ÄúI have felt sad or
miserable‚Äù) measured on a 4-point scale, yielding total scores ranging from 0 to 30 where higher
scores indicate more severe symptoms. Whereas participants in the pre-pandemic cohort
completed a modified version of the EPDS in which they were asked to report on their
symptoms ‚Äúduring pregnancy,‚Äù participants in the COVID-19 cohort were asked to report on
their symptoms in the ‚Äúpast 7 days.‚Äù According to a recent meta-analysis, the EPDS has high
sensitivity and specificity for detecting depression in pregnant women at a cut-off score of ‚â• 11
(Levis, Negeri, Sun, Benedetti, & Thombs, 2020). Internal consistency of the EPDS quantified
with Cronbach‚Äôs ‚ç∫ was good in both cohorts (pre-pandemic cohort=.89, COVID-19 cohort=.85).
COVID-19 Stress and Adversity. Participants in the COVID-19 cohort responded to a
series of questions probing their experiences related to the pandemic, developed by Drs. Moriah
Thomason and Michelle VanTiegham at New York University and Drs. Alice Graham and Elinor
items that asked about adversity (i.e., negative life event related due to the pandemic; e.g., a
checklist of changes to prenatal care due to COVID-19, including change from planned vaginal
to induction or C-section, cancellation or reduction in prenatal care visits) or psychosocial stress
(i.e., affective responses to the pandemic; e.g., ‚ÄúHow concerned are you about possible
changes to your medical care during your baby‚Äôs birth as a result of COVID-19‚Äù). We did not
include items that assessed adversity or stress unrelated to COVID-19 or items that overlapped
with symptoms of depression. Overall, we examined 16 indicators of COVID-19 stress and
Individual-level risk and protective factors. Using the survey developed by Thomason
increase risk for or protect against stress and adversity related to the pandemic. These survey
participants had a history of serious medical conditions (e.g., diabetes, lung disease), a history
of a mood or anxiety disorder, were at high risk for COVID-19 due to existing medical
conditions, their number of existing prenatal medical conditions (e.g., gestational diabetes,
hypertension), their number of personal environmental resources (e.g., phone, internet, privacy
at home, outdoor space), the extent to which they felt supported by their prenatal care team (not
very well supported, somewhat well supported, or very well supported), how well they currently
felt supported by their social network (from 1 (Not supported) to 7 (Very supported) and how
well they felt supported prior to COVID-19, from which we calculated change in social support
due to COVID-19 (see Supplementary Material for distributions of each individual-level risk and
protective factor).
Community-level risk factors. For participants in the COVID-19 cohort, we first
geocoded their current addresses using the Census Geocoding API and the ‚Äútidygeocoder‚Äù
package in R (Cambon, 2020). We next used the ‚Äútigris‚Äù package in R (Walker, 2020) to identify
the census tract code corresponding to each participant‚Äôs geolocation. The 343 participants who
provided complete addresses in California were then matched based on their census tract
codes with population characteristics data from the CalEnviroScreen 3.0
Area. We focused on the following 8 community-level indicators of sensitive health and
socioeconomic burden: asthma (rate of emergency room (ER) visits for asthma per 10,000
people); cardiovascular disease (rate of ER visits for heart attacks per 10,000 people); low birth
weight (% births of low weight infants in population); low educational attainment (% of
population > age 25 years with < high school education); housing burden (% of population that
is both low income and paying > 50% of income for housing); linguistic isolation (% limited
English-speaking households); poverty (% of population with income < twice the federal poverty
line); and unemployment (% of population > age 16 years, eligible for workforce, and
unemployed). The indicators were quantified by the census tract percentile relative to the
distribution across all 8,057 tracts in California (see Supplementary Material for distributions of
each community-level indicator within this sample).
Statistical Analysis
Statistical analyses were conducted in R version 4.0.2 (R Core Team, 2020) and Mplus
version 8 (Muth√©n & Muth√©n, 2017). Data and code for analyses is available at:
Aim 1: Examine Prenatal Depressive Symptoms in Matched Samples of Women
Pregnant Prior to and During the COVID-19 Pandemic. Analyses for Aim 1 focused on
subsets of matched participants from the pre-pandemic and COVID-19 cohorts. All matched
participants were currently residing in the San Francisco Bay Area at the time of data collection
We used Optimal Nearest Neighbor Matching (Stuart, 2010) implemented in the ‚ÄúMatchIt‚Äù
package in R (Ho, Imai, King, & Stuart, 2011) to identify matched samples from each cohort with
the smallest average absolute distance across all matched pairs. Distance was quantified by the
propensity score estimated from a logistic regression of cohort on age, parity, gestational
weeks, number of children, marital status, race/ethnicity, income, education, employment status,
and history of treatment for mental health difficulties or substance use (see the Supplementary
Material for detail methods and results of matching procedures). We used a Welch‚Äôs t-test and
multiple ordinary least squares (OLS) regression to test the hypothesis that participants who are
pregnant during the COVID-19 pandemic have higher prenatal depressive symptoms than do
matched participants who were pregnant prior to the pandemic.
Aim 2: Explore the Latent Structure of COVID-19 Stress and Adversity among
Pregnant Women. Analyses for Aim 2 focused on the full sample participants in the COVID-19
cohort. We used exploratory factor analysis (EFA) to examine the dimensionality of stress and
included a mix of continuous normal variables, continuous variables with floor effects (i.e.,
censored from below), and count variables (modeled with Poisson regression), the EFA was
estimated with maximum likelihood robust standard errors using a numerical integration
algorithm (MLR; Muth√©n & Muth√©n, 2017). Missing data were handled using Full Information
Maximum Likelihood and factors were allowed to correlate using an oblique rotation (‚Äúgeomin‚Äù;
Muth√©n & Muth√©n, 2017). Traditional fit statistics for EFA are not calculated when using MLR.
Therefore, we determined the number of factors based on chi-squares tests comparing model fit
for a model with one additional factor, the Bayesian Information Criterion (BIC) values, and the
interpretability of the solution. We removed items with high cross-loadings (‚â•.30) before
identifying a final model. We extracted estimated factors scores based on the final EFA solution.
Aim 3: Identify Individual- and Community-Level Risk and Protective Factors for
COVID-19 Stress and Adversity in Pregnant Women. Analyses for Aim 3 focused on
participants who resided in California and provided valid addresses that could be geocoded and
matched by census tract to the CalEnviroScreen dataset. Among these participants, we used
elastic net (EN) regularized regression with the ‚Äúglmnet‚Äù package in R (Jerome, Hastie, Simon,
& Tibshirani, 2010), employing a full EN penalty (‚ç∫=.50) and an expected gaussian distribution,
to explore the associations between potential individual- and community-level variables that
may enhance risk or be protective and estimated factor scores for COVID-19 stress and
models in which estimated scores for each factor identified in the EFA in Aim 2 served as
dependent variables. Given that EN models implement list-wise deletion, participants who were
missing values for at least one of the individual-level variables were removed from the analysis,
yielding a final sample for Aim 3 of 319 women. We performed leave-one-out cross-validation
(LOOCV; James, Hastie, & Tibshirani, 2013) using the cv.glmnet function to determine the
largest Œª (i.e., hyperparameter, regularization value) associated with the smallest mean-squared
error (i.e., ‚Äúlambda.min‚Äù), which yields a sparse matrix of non-zero coefficients. In order to
determine model performance, we computed R2 based on predicted and observed values. To
aid interpretation of the coefficient estimates, we computed zero-order effect sizes with 95%
confidence intervals for the variables that were selected by the EN models.
Aim 4: Examine the Associations of Dimensions of COVID-19 Stress and Adversity
with Prenatal Depressive Symptoms during the COVID-19 Pandemic. We used a multiple
OLS linear regression to examine the associations between dimensions of COVID-19 stress
and adversity and prenatal depressive symptoms. Specifically, in a single model, prenatal
depressive symptoms were regressed on the estimated scores for each factor identified in the
EFA in Aim 2. Finally, to identify single variables that may be used in a clinical setting to identify
women experiencing the specific types of COVID-19 stress and adversity that are most strongly
associated with increased risk for prenatal depression, we conducted an additional EN
regularized regression to examine the associations between each of the indicators of COVID-19
stress and adversity entered in the EFA model in Aim 2 and prenatal depressive symptoms.
Results
Sample Characteristics
community-level risk and protective factors examined in Aim 3.
Pre-pandemic cohort: Participants in the pre-pandemic cohort were ages 20-44 years
(mean [SD]=32.55 [5.04]) and 12-37 gestational weeks (mean gestational age [SD]=24.44 [5.47]
weeks). Eighty-three percent were married or partnered and 27% were primiparous. Participants
reported living with 0-4 children (mean [SD]=0.88 [1.10]) 1-7 adults household (mean [SD]=2.38
[1.12]). They reported their race and ethnicity as follows: 54% White, 21% Asian or Asian
American, 10% Hispanic or Latinx, 3% Black or African American, 3% Native Hawaiian/Pacific
Islander, 1% Native American/Alaskan Native, and 6% ‚Äúother.‚Äù Although income-to-FPL ratios
ranged from 0.06-11.28, participants tended to have higher incomes relative to national norms
(8% had incomes ‚â§ 200% of the FPL; mean [SD] income-to-FPL ratio=5.61 [2.52]) and most
were highly educated (78% had ‚â• a 4-year college degree). Sixty-eight percent had paid jobs,
17% were stay-at-home caregivers, 2% were students, and 10% were unemployed. Sixty-seven
percent of participants had previously received treatment for mental health difficulties or
substance abuse. With respect to depressive symptoms, scores on the EPDS ranged from 0-21
(mean [SD]=7.22 [5.35]; 25% of participants scored ‚â• the cut-off score of 11, indicating possible
depression (18% scored ‚â• 13; 10% scored ‚â• 15).
COVID-19 cohort: Participants in the COVID-19 cohort were ages 19-50 years (mean
[SD]=33.69 [4.38]) and between 4-41 gestational weeks (mean [SD]=26.79 [8.81]). Ninety-
seven percent were married or partnered and 49% were primiparous. Participants reported
living with 0-9 children (mean [SD]=0.63 [0.93]) and 1-8 adults (mean [SD]=2.30 [0.81]). They
reported their race and ethnicity as follows: 62% White, 17% Asian or Asian American, 11%
Hispanic or Latinx, 7% multi-racial/multi-ethnic, 1% Black or African American, <1% Native
American/Alaskan Native, and <1% Native Hawaiian/Pacific Islander. Income-to-FPL ratios
ranged from 0.21-14.60 (7% had incomes ‚â§ 200% of the FPL; mean [SD] income-to-FPL ratio =
8.47 [4.13]) and 84% of participants had ‚â• a 4-year college degree. Seventy-six percent had
paid jobs, 10% were stay-at-home caregivers, 2% were students, 3% reported ‚Äúother‚Äù types of
employment, and 8% said they were unemployed and looking for work. Forty-one percent of
participants had previously received treatment for mental health difficulties or substance abuse.
Scores for prenatal depressive symptoms ranged from 0-26 in the full COVID-19 cohort (mean
[SD]=9.54 [5.21]); 42% of participants scored ‚â•11, indicating possible depression (29% scored ‚â•
13; 17% scored ‚â• 15). Three participants reported that they had tested positive for COVID-19.
Aim 1: Examine Prenatal Depressive Symptoms in Matched Samples of Women Pregnant
Prior to and During the COVID-19 Pandemic
Optimal Nearest Neighbor Matching yielded a subset of 164 women from the pre-
pandemic and COVID-19 cohorts (n=82 from each cohort) who were similar in age, parity,
gestational weeks, number of children, marital status, race/ethnicity, income, education,
employment status, and history of treatment for mental health difficulties or substance use. The
standardized mean difference [SMD] for the propensity scores based on these variables was
0.15 after matching and the variance ratio was 1.66, indicating acceptable balance between
groups (Rubin, 2006; see Supplementary Material for detailed methods and results for matching
procedures). Following matching, the groups from each cohort did not differ significantly on any
of the variables used in the matching procedure. Because the sample of pre-pandemic
participants was recruited to be enriched for a history of MDD or early life adversity, the 82
matched participants from the COVID-19 cohort had higher depressive symptoms (mean
[SD]=10.84 [5.64]) than did other participants in this cohort (mean [SD]=9.37 [5.13];
t(99.06)=2.25, p=.027, SMD [95% CI]=0.28 [0.05, 0.51]), but did not differ significantly in
estimated factor scores for COVID-19 objective adversity or subjective stress (see Aim 2). Thus,
differences between matched ‚Äúpre-pandemic‚Äù and ‚ÄúCOVID-19‚Äù participants should be
interpreted as differences between two groups of women at relatively higher risk for current
depression who differ based on whether they were pregnant prior to or following the onset of the
pandemic.
As hypothesized, women who were pregnant during the pandemic had significantly
higher levels of prenatal depression than did ‚Äúpre-pandemic‚Äù pregnant women (Welch‚Äôs
and was similar in effect size when adjusting for age, gestational weeks, marital status, parity,
number of children, race/ethnicity, low income status, education, employment status, and history
of treatment for mental health difficulties or substance use (B=3.17, SE=0.80, t(152)=3.95, p <
.001, Œ≤[95% CI]=0.56, [0.28, 0.84]). In addition, participants in the COVID-19 cohort were
significantly more likely than were ‚Äúpre-pandemic‚Äù participants to score above the clinical cutoff
(‚â•11) on the EPDS indicating possible depression (ùõò 2(1)=10.31, p=.001). Whereas 25% of
participants in the pre-pandemic cohort had possible depression, half (51%) of participants in
the COVID-19 cohort had possible depression. Expressed in terms of relative risk, participants
in the COVID-19 cohort were twice as likely to have possible depression than were participants
in the pre-pandemic cohort.
during the COVID-19 pandemic than in matched pregnant women in a pre-pandemic
prenatal depressive symptoms for each participant (dots), the medians and interquartile ranges
of prenatal depressive symptoms (box plots), and the distribution of prenatal depressive
symptoms (flat violin plots).
Aim 2: Explore the Latent Structure of COVID-19 Stress and Adversity among Pregnant
Women
We compared models with one, two, and three factors (models with >3 factors did not
square tests of model fit and the BIC values, more complex models provided better fits to the
data. Specifically, a 2-factor solution (BIC=43,752.83) fit better than a 1-factor solution
(BIC=44,252.81.16; ùõò2(15)=581.11, p<.001), and a 3-factor solution (BIC=43,425.15) fit better
than a 2-factor solution (ùõò2(14)=461.49, p<.001). When items with high oblique rotated cross-
loadings (>|.30|) were removed (distress due to current financial/employment impacts, distress
due to expected financial/employment impacts, and restrictions on activity), leaving 13 items in
the model, we observed a similar pattern. Specifically, the 2-factor solution provided a
significantly better fit to the data than the 1-factor solution (ùõò2(12)=591.18, p<.001), and the BIC
was reduced in the 2-factor compared to the 1-factor model and in the 3-factor model compared
to the 2-factor model (BIC 36,788.16; BIC 36,283.36; BIC =36,100.37). However,
1-factor= 2-factor= 3-factor
the 3-factor model remained uninterpretable due high cross-loadings. In contrast, the 2-factor
solution contained no high cross-loadings and was interpretable.
In order to maximize both model fit and interpretability, we selected the 2-factor solution
from the model of the 13 indicators of COVID-19 stress and adversity presented with their factor
objective COVID-19 adversity, was defined by three items assessing extant or expected
negative life events due to COVID-19, including the number of current changes in the
participant‚Äôs or the participant‚Äôs partner‚Äôs employment and finances (e.g., loss of job, loss of
health insurance, reduced ability to afford childcare), the number of expected changes in
employment and finances, and the number of current changes to the participant‚Äôs prenatal care
(e.g., changed from planned vaginal birth to induction or C-section, change in prenatal care
providers, cancellation or reduction of prenatal care visits).
The second factor, which we labeled subjective COVID-19 stress, was defined by 10
items assessing affective responses to COVID-19. Items that loaded onto this factor included
those assessing the severity of participants‚Äô concerns about the impact of COVID-19 on the
social support and medical care they would receive during labor and delivery, their infant‚Äôs
health, and their capacity to care for their infant following birth. Items assessing the severity of
participants‚Äô distress due to COVID-19 also loaded on this factor, including distress due to the
possibility that they or their family would contract COVID-19, the potential for reduced access to
material resources (e.g., baby supplies), health care, and positive social interactions because of
COVID-19, and distress due to current disruptions in social interactions because of COVID-19.
Finally, participants‚Äô ratings of the overall impact of COVID-19 on their daily life and the valence
of this impact loaded onto this subjective stress factor.
be used in analyses for Aims 2-3. Scores for each factor were normally distributed (see
Supplementary Material).
of overall impact, lower scores indicate that the impact of the pandemic was viewed as having a
more negative impact on life.
Variable Mean (SD) Range
2.29 (1.39) 0-6
Changes to prenatal care
4.06 (2.40) 0-7
Concern for birth medical care
4.96 (2.14) 0-7
Concern for birth social support
3.52 (2.85) 0-7
Concern for caregiving capacity
4.04 (2.66) 0-7
Concern for infant's health
1.44 (0.62) 0-4
Self-quarantine/government restrictions
4.71 (2.88) 0-19
Current employment/financial impacts
3.87 (3.69) 0-22
Expected employment/financial impacts
2.69 (2.06) 0-6
Distress due to current financial impacts
2.98 (2.08) 0-6
Distress due to expected financial impacts
3.31 (2.02) 0-6
Distress due to potential family illness
1.86 (1.99) 0-6
Distress due to own potential illness
1.47 (0.69) 0-3
Distress due to reduced access
2.76 (1.94) 0-6
Distress due to social disruptions
4.14 (1.21) 0-6
Overall impact to daily life
-1.74 (1.04) -3-3
Valence of overall impact
of stress and adversity related to COVID-19.
Aim 3: Identify Individual- and Community-Level Risk and Protective Factors for COVID-
19 Stress and Adversity in Pregnant Women
EN regression model in which estimated factor scores of objective COVID-19 adversity were the
dependent variable. Next, we repeated this analysis with estimated factor scores of subjective
and 5.
The LOOCV of the EN model of objective COVID-19 adversity identified an optimal
Œª=.04, resulting in 11 variables with non-zero coefficients that explained 11% of the variance in
objective adversity. Based on zero-order effect size, women who were immigrants to the U.S,
had histories of a mood/anxiety disorders and had more prenatal medical complications were
higher in objective adversity. Although the associations were weaker in effect size, women who
received greater support from their prenatal care team and had more environmental resources
were lower in objective adversity.
The LOOCV of the EN model of subjective COVID-19 stress identified an optimal Œª=.07,
resulting in 12 variables with non-zero coefficients that explained 18% of the variance in
subjective stress. Based on zero-order effect size, women who were at high risk for COVID-19
due existing medical conditions, were persons of color, were primiparous, had histories of a
mood/anxiety disorder, resided in census tracts that were higher relative to other tracts in the
percent of the population with less than a high school education, and resided in census tracts
where a greater percent of the population was limited English-speaking were higher in
subjective stress. In contrast, women with more environmental resources, who received greater
support from their prenatal care team, and who experienced less deterioration or greater
improvement in social support from prior to during the pandemic were lower in subjective stress.
community-level risk and protective factors. Descriptive statistics are for the 343 participants who provided
valid addresses in California. Elastic net and effect size estimates are for the 319 participants included in the
elastic net regression. FPL=Federal Poverty Line. Objective adversity and subjective stress are estimated
variables, Pearson‚Äôs r values continuous variables., and Spearman‚Äôs ùúå values for ordinal or count data.
Elastic Net Estimate /
zero-order
N (%) or effect size [95% CI]
Variable Range
Mean (SD) Objective Subjective
Adversity Stress
R2=.11 R2=.18
Individual-level Factors
0.10 0.13
Primiparous 173 (50)
.15 [-.07, .37] .28 [.06, .50]
Previous miscarriage
106 (31)
or abortion
History of serious
80 (23)
medical conditions
History of mood or anxiety 0.04 0.03
93 (27)
disorder .20 [-.05, .45] .26 [.01, .51]
High risk for COVID-19 due to 0.10
83 (24)
existing medical conditions .44 [.18, .70]
0.11
Person of color 136 (39)
.31 [.09, .54]
0.07
Immigrant to U.S. 69 (20)
.20 [-.07, .47]
Low income according to FPL
Multi-bedroom housing 279 (81)
0.04 0.03
Age
.06 [-.05, .17] .03 [-.08, .14]
-0.11 -0.10
Environmental resources 4.21 (0.85) 0-5
-.11 [-.21, <.01] -.16 [-.26, -.05]
0.15 0.13
Prenatal medical conditions 0.22 (0.48) 0-2
.20 [.09, .30] .17 [.06, .28]
-0.12 -0.10
Support from prenatal care team 1.60 (0.56) 0-2
-.14 [-.24, -.03] -.13 [-.23, -.02]
Current social support 3.91 (1.58) 0-6
-0.11
Change in social support -0.64 (1.46) -5-4
-.16 [-.27, -.05]
Community-level Factors
0.05
Rate of ER visits for asthma 39.13 (28.65) 0.02-99.61
.07 [-.04, .18]
Rate of ER visits for
29.52 (23.85) 0.32-95.72
heart attacks
0.01
Rate of low weight births 43.73 (27.64) 0.00-99.82
.05 [-.06, .16]
0.13
% low educational attainment 32.40 (24.22) 0.18-91.72
.15 [.05, .25]
% housing burdened 39.87 (25.58) 0.27-98.95
0.07 0.01
% limited English-peaking 47.94 (26.27) 0.00-99.34
.06 [-.05, .17] .11 [.01, .29]
-0.09 -0.03
% in poverty 30.79 (21.67) 0.24-90.80
-.04 [-.15, .07] .03 [-.08, .14]
% unemployed 29.53 (22.60) 0.04-98.45
net regression of estimated factor scores for objective COVID-19 adversity. d = Cohen‚Äôs
standardized mean difference. ùúå = Spearman‚Äôs rank-order correlation. r = Pearson‚Äôs correlation.
Values within brackets are lower and upper bounds of 95% confidence intervals.
net regression of estimated factor scores for subjective COVID-19 stress. d = Cohen‚Äôs
standardized mean difference. ùúå = Spearman‚Äôs rank-order correlation. r = Pearson‚Äôs correlation.
Values within brackets are lower and upper bounds of 95% confidence intervals.
Aim 4: Examine the Associations of Dimensions of COVID-19 Stress and Adversity with
Prenatal Depressive Symptoms during the COVID-19 Pandemic
In the full sample of participants in the COVID-19 cohort and when covarying for scores
of objective COVID-19 adversity, women who were higher in subjective COVID-19 stress had
significantly higher prenatal depressive symptoms (Œ≤=0.44, 95% CI [0.35, 0.52], p<.001,
R2=.17). In contrast, although the zero-order association between objective COVID-19 adversity
and prenatal depressive symptoms was statistically significant (r=0.24, p<.001), women‚Äôs
scores on this factor were not significantly associated with their symptoms when covarying for
their subjective stress (Œ≤=0.04, 95% CI [-0.04, 0.12], p=.356).
Finally, we sought to identify single indicators of COVID-19 stress and adversity that
were most strongly associated with prenatal depressive symptoms. Given that factor scores are
difficult to interpret, identifying single indicators may aid in characterizing our findings and
translating them to clinical settings. The LOOCV for the EN model of depressive symptoms
identified an optimal Œª=.02, resulting in 9 variables with non-zero coefficients, 7 of which were
variables that had loaded onto the subjective COVID-19 stress factor and two of which were
variables that had loaded onto the objective COVID-19 adversity factor. We present the
Listed in order of zero-order effect size, these variables were as follows: distress due to social
disruptions (EN estimate=0.20), distress due to reduced access to resources (EN
estimate=0.18), severity of overall impact of COVID-19 on daily life (EN estimate=-0.06),
valance of overall impact of COVID-19 (EN estimate=-0.11), concern about the availability of
social support during birth (EN estimate=0.16), distress that family would contract virus (EN
estimate=0.04), distress that participant would contract virus (EN estimate=0.02), current
employment/financial impacts (EN estimate=0.09), number of changes to prenatal care due to
COVID-19 (EN estimate=0.02).
and adversity and prenatal depressive symptoms. When estimated scores for both factors
were entered together, only Subjective COVID-19 stress remained significantly associated with
prenatal depressive symptoms.
in elastic net regression of prenatal depressive symptoms. ùúå = Spearman‚Äôs rank-order
correlation. r = Pearson‚Äôs correlation. Values within brackets are lower and upper bounds of
95% confidence intervals
Discussion
We examined pregnant women‚Äôs experiences of the COVID-19 pandemic following the
initial ‚Äúshelter-in-place‚Äù response in the San Francisco Bay Area. Distinguishing between
adversity (i.e., negative life events) and stress (i.e., affective responses to negative life events;
Barrero-Castillero et al., 2019), we explored the latent structure of women‚Äôs experiences of the
pandemic and searched for individual- and community-level factors that may increase risk or
protect against stress and adversity related to COVID-19. We investigated whether women who
were pregnant during this period had elevated depressive symptoms compared to a matched
sample of women who were pregnant prior to the pandemic. Finally, we examined whether
women who experienced more severe stress and adversity related to the pandemic had more
severe depressive symptoms and identified the specific forms of stress and adversity that were
most strongly associated with their symptoms.
Similar to previous studies of the impact of the COVID-19 pandemic in the general
population (Ettman et al., 2020; Nelson et al., 2020), we found evidence that the onset of the
pandemic led to increased depressive symptoms specifically among pregnant women.
Concerningly, compared to historical levels of prenatal depression, the discrepancy in
depressive symptoms during COVID-19 that we observed in pregnant women is even greater
than has been found when comparing general population samples during COVID-19 to pre-
pandemic samples. In the full sample of 725 pregnant women that we surveyed in March-May
2020, over 40% reported symptoms indicating possible depression when using a cutoff score of
‚â• 11 on the EPDS (Levis et al., 2020). In comparison, a systematic review of studies including
over 35,000 women conducted in developed countries prior to the pandemic found that the
average rate of prenatal depression was 17% (Underwood, Waldie, D‚ÄôSouza, Peterson, &
Morton, 2016). Moreover, supporting our hypotheses, we found that compared to a matched
sample of women who were pregnant prior to the pandemic, women who were pregnant during
the pandemic were twice as likely to have possible depression.
Although, outside the context of COVID-19, major depression is no more common in
pregnant women than in non-pregnant women (Ashley, Harper, Arms-Chavez, & LoBello, 2016),
pregnant women may be especially vulnerable to the depressogenic effects of stress and
adversity related to the pandemic due to the dramatic biological and psychosocial changes that
occur during pregnancy (C√°rdenas et al., 2020). Given this plasticity, elevations in depressive
symptoms in pregnancy, even when temporary, may have lasting effects on maternal and fetal
neurobiology. In fact, the transition to parenthood is theorized to be a ‚Äúcritical window for adult
health‚Äù that may shape trajectories for physical and psychological health in midlife (Saxbe et al.,
2018). For example, depression in pregnancy has been associated with changes in maternal
prenatal inflammation, indicated by elevations in pro-inflammatory cytokines (Gustafsson et al.,
2018; Osborne et al., 2018). In turn, maternal inflammatory biomarkers have been linked with
subsequent infant stress responses and negative affect (Gustafsson et al., 2018; Osborne et al.,
2018) and variation in neonatal brain structure and function (Rasmussen et al., 2019; Rudolph
et al., 2018). Women who experience prenatal depression may also behave differently with their
infants. For example, they are more likely to cease exclusive breastfeeding earlier in the
postpartum period (Figueiredo, Can√°rio, & Field, 2014) and to report poorer bonding with their
infants postnatally (Rossen et al., 2016). Because elevations in prenatal depressive symptoms
may have enduring consequences for maternal‚Äìchild health, policymakers and clinicians should
consider measures to support women who were pregnant during this pandemic even if their
depressive symptoms have since remitted.
A critical step in understanding the relation between the impact of the pandemic and risk
for prenatal depression is to characterize the nature of women‚Äôs experiences during this period.
We found that women‚Äôs experiences related to COVID-19 fell along the two dimensions of
objective COVID-19 adversity (i.e., extant or expected negative life events due to the pandemic)
and subjective COVID-19 stress (i.e., affective responses to negative life events due to the
pandemic). Experiences of objective adversity due to COVID-19 included those that are
common to the general population (e.g., changes to finances and employment) and those that
specifically affect pregnant women (e.g., changes to prenatal care). Similarly, subjective stress
due to COVID-19 involved women‚Äôs fears that they or their family would contract the virus, as
well as concerns about the medical care and social support they would receive during labor and
delivery. We found that, above and beyond their experiences of objective adversity due to
COVID-19, women who experienced more severe subjective stress had significantly higher
depressive symptoms. In fact, subjective stress due to COVID-19 explained 17% of the variance
in women‚Äôs depressive symptoms.
Our findings are consistent with those of other recent studies that have distinguished
between the impacts of objective exposure to adversity and subjective stress severity on risk for
psychopathology. For example, subjective reports, rather than objective measures, appear to
explain risk for psychopathology following childhood maltreatment (Danese & Widom, 2020).
Perceived socioeconomic standing is more strongly associated with subjective wellbeing than is
objectively measured income and education‚Äîa finding that is not solely explained by common
method variance (Tan, Kraus, Carpenter, & Adler, 2020). Most relevant to the current study,
Nelson et al. (2020) found in a general population sample from across the U.S., Canada, and
Europe, that individuals‚Äô levels of subjective concern about COVID-19 were more strongly
associated with their depressive symptoms than were epidemiological data signifying objective
risk (e.g., country confirmed case). Nonetheless, objective changes to the environment,
including widespread disruptions in the functioning of society due to COVID-19 and the real
threats that this virus poses to maternal‚Äìchild health (Mayopoulos et al., 2020; Woodworth et
al., 2020; Zambrano et al., 2020) create the conditions for susceptible individuals to experience
subjective stress. Our findings suggest that in addition to policies that help to mitigate
disruptions to the environment due to the pandemic (e.g., measures to inhibit the transmission
of the virus, payments to families for recovery of financial losses), treatments that focus on
cognitions about the self and the environment may help to alleviate depressive symptoms in
pregnant women during this period.
With implications for the allocation of resources to support recovery from the
psychosocial sequelae of the pandemic, we identified individual- and community-level factors
that were associated with risk for the experience of objective adversity and subjective stress
during this period. Specifically, women who were immigrants to the U.S., who had a history of a
mood or anxiety disorder, and who had prenatal medical conditions (e.g., gestational diabetes,
small fetal size) reported greater objective adversity due to COVID-19. Women who had
histories of mood or anxiety disorders and who had existing prenatal medical conditions also
reported more severe subjective stress. Additional risk factors for more severe subjective stress
included identifying as a person of color, having a medical condition that increased one‚Äôs risk of
contracting COVID-19, and living in communities that had higher rates of low education and
linguistic isolation. It is well-documented that the pandemic has had an unequal impact in terms
of transmission and mortality; members of our society who are medically sensitive or experience
systemic discrimination are most at risk for contracting the virus and dying from it (Karaca-
Mandic, Georgiou, & Sen, 2020). Supporting the results of another recent study (Preis et al.,
2020), our findings suggest that, even in the initial months following the onset of the pandemic
in the U.S., women who were already experiencing challenges due to socioeconomic inequality
and mental and physical health were the most vulnerable to experiencing adversity (i.e.,
disruptions to their finances, employment, and obstetric care) and stress (i.e., fears and
concerns about the impact of the pandemic).
It is important to consider limitations of the current study. This was a convenience
sample of women recruited through online advertisements in the San Francisco Bay Area.
Therefore, our sample is only representative of women with access to the internet who live in
this geographic region. Due to our study design, it is likely that we did not capture the
experiences of some individuals who may be the most severely exposed to stress and adversity
related to COVID-19 (e.g., individuals in severe poverty, individuals who do not have time to
devote to participating in research). Although our study was racially and ethnically diverse, few
Black or Indigenous women participated. In addition, the sample for our study tended to be
highly educated, likely reflecting the demands, due to high cost of living, of residing in the Bay
Area. Although we matched women who were surveyed following the onset of the COVID-19
pandemic to women who were pregnant prior to the pandemic in order to draw inferences about
the potential impact of the pandemic on depressive symptoms, it is possible that additional
unmeasured variables differentiate these two groups of women (e.g., personality characteristics
linked to willingness to participate in online versus in-person research). Importantly, we used a
cross-sectional observational design in this study. Therefore, we cannot conclude that the onset
of the pandemic caused increases in women‚Äôs depressive symptoms, nor can we speak to how
women‚Äôs experiences of stress, adversity, and depressive symptoms have changed over time
as the pandemic has unfolded. In light of recent data from the U.K. indicating that depressive
symptoms declined within-individuals across the first 20 weeks following the initial ‚Äúlockdown‚Äù
response, it is possible that many of the women who participated in the current study have since
recovered from their initially high levels of symptoms. Nonetheless, the U.S. has remained
among the highest risk countries for COVID-19 since March 2019; as of late December 2020,
California has the highest daily case rate in the nation.
Overall, these findings suggest that pregnant women experienced elevated levels of
depressive symptoms following California‚Äôs ‚Äúshelter-in-place‚Äù measures initiated in response to
the COVID-19 pandemic in March 2020. Both individual- and community-level factors tied to
social and economic inequality appeared to enhance vulnerability to stress and adversity related
to COVID-19. Above and beyond their experiences of financial hardship, disruptions to
employment, and changes to their prenatal care, women‚Äôs subjective stress responses,
including the degree to which they felt distressed about the impact of the pandemic on their and
their future infants‚Äô lives, were associated with their depressive symptoms. Unfortunately, prior
to COVID-19, the U.S. already lagged behind other countries in its treatment of pregnant
women, mothers, and infants. Among similarly developed countries, the U.S. has the highest
maternal and child mortality rates (Gunja, Fitzgerald, & Zephyrin, 2020; Thakrar, Forrest,
Maltenfort, & Forrest, 2018) and is the only developed country without a paid family leave policy
(U.S. Department of Labor, 2012). Given the possibility that even temporary increases in
depressive symptoms during pregnancy may have long-lasting consequences for maternal‚Äì
child health, it is critical that research with pregnant women exposed to the psychosocial impact
of COVID-19 continues even as policy-makers consider essential and significant support for
pregnant and postpartum women during this period and beyond.